<DOC>
	<DOCNO>NCT03058185</DOCNO>
	<brief_summary>Laminopathies emerinopathies complex group rare disorder due mutation A-type lamins ( LMNA ) Emerin ( EMD ) gene . Among , disorder affect skeletal and/or cardiac muscle frequent clinical manifestation , cardiac disease major cause death . Remarkable progress make description clinical genetic spectrum disease since 1990 's . Until , precise phenotype/genotype relation remain elusive . As several neuromuscular disorder , apart symptomatic treatment , currently specific treatment prevent slow progression disease . The OPALE registry multicentre web-based registry dedicate laminopathy emerinopathy French patient . OPALE approve ethical regulatory authority . Its main inclusion criterion presence proven pathogenic LMNA and/or EMD gene mutation . The OPALE objective provide tool allow detailed capture patient genetic , neurological , cardiological , endocrinological respiratory assessment , order allow ) precise disease natural history , ii ) evaluation different disease complication frequency iii ) identification prognosis factor .</brief_summary>
	<brief_title>Observatoire Des Patients Atteints de Laminopathies et Emerinopathies ( Obeservatory PAtients With Laminopathies Emerinopathies )</brief_title>
	<detailed_description />
	<criteria>presence proven pathogenic LMNA and/or EMD gene mutation sign informed consent sign inform refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lamin A/C</keyword>
	<keyword>Emerin</keyword>
</DOC>